Investor

Financial information, reports, calendar and more

Press & News

2018-09-24

Solna, Sweden, September 24, 2018. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing...[read more]

Annual Reports

2017
Årsredovisning 2017 (Swedish) – May 23, 2017

2016
Årsredovisning 2016 (Swedish) – June 8, 2017

2015
Årsredovisning 2015 (Swedish) – April 29, 2016

2014
Årsredovisning 2014 (Swedish) – June 2, 2015

2013
Årsredovisning 2013 (Swedish) – April 17, 2014

2012
Årsredovisning 2012 (Swedish) – June 7, 2013

Affibodys latest Press releases

2018-09-24

New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment

Solna, Sweden, September 24, 2018. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing a portfolio of innovative drug...[read more]

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

Interim Report Q2 (August 23, 2018)

Investor information